Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A negative regulatory element (NRE) is located immediately upstream of the upstream regulatory sequence of core promoter and second enhancer of human hepatitis B virus (HBV). NRE represses the transcription activation function of the upstream regulatory sequence of core promoter and the second enhancer. In this study, we described the cloning and characterization of an
NRE-binding protein
(
NREBP
) through expression cloning.
NREBP
cDNA is 8266 nucleotides in size and encodes a protein of 2386 amino acids with a predicted molecular mass of 262 kDa. Three previously described cDNAs,
DBP-5
, SONB, and SONA, are partial sequence and/or alternatively spliced forms of
NREBP
. The genomic locus of the
NREBP
/SON gene is composed of 13 exons and 12 introns. The endogenous
NREBP
protein is localized in the nucleus of human
hepatoma
HuH-7 cells. Antibody against
NREBP
protein can specifically block the NRE binding activity present in fractionated nuclear extracts in gel shifting assays, indicating that
NREBP
is the endogenous nuclear protein that binds to NRE sequence. By polymerase chain reaction-assisted binding site selection assay, we determined that the consensus sequence for
NREBP
binding is GA(G/T)AN(C/G)(A/G)CC. Overexpression of
NREBP
enhances the repression of the HBV core promoter activity via NRE. Overexpression of
NREBP
can also repress the transcription of HBV genes and the production of HBV virions in a transient transfection system that mimics the viral infection in vivo.
...
PMID:Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON. 1130 77
3-(4-(Benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate (DPB-5) is a synthetic benzothiazole derivative. In the present study, we revealed that DPB-5 had strong cytotoxicity to induce cell apoptosis, which was mediated by ROS. And DPB-5 was more cytotoxic toward
hepatoma
cells than toward normal hepatic cells, which was resulted from the greater susceptibility of the malignant cells to ROS.
DBP-5
caused massive ROS accumulation and GSH decrease, which lead to MMP disruption, caspase activation and finally induced cell apoptosis. Additionally, rotenone, an inhibitor of mitochondria electron transport system, effectively blocked the ROS elevated effect of DPB-5, which suggested that DPB-5-induced ROS generated from the mitochondria. Further studies showed that DPB-5-induced cell apoptosis through caspases-cascade, but failed to activate caspase-9. Hence, we concluded that DPB-5-induced Hep G2 cells apoptosis via a ROS-mediated pathway which was caspase-dependent but did not rely on caspase-9.
...
PMID:3-(4-(Benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate induced Hep G2 cell apoptosis through a ROS-mediated pathway. 2001 82